Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS

scientific article published on 25 June 2015

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043916979
P356DOI10.1007/S00216-015-8828-6
P698PubMed publication ID26108532

P50authorSimon D. BrandtQ47819756
Hans H. MaurerQ52760572
P2093author name stringMarkus R Meyer
Volker Auwärter
Andreas G Helfer
Julian A Michely
Achim T Caspar
P4510describes a project that usesgas chromatography-mass spectrometryQ873009
P433issue22
P407language of work or nameEnglishQ1860
P304page(s)6697-6719
P577publication date2015-06-25
P1433published inAnalytical and Bioanalytical ChemistryQ2845280
P1476titleStudies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS
P478volume407

Reverse relations

cites work (P2860)
Q5538392825C-NBOMe Ingestion.
Q3956958525C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry
Q93384911Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics
Q53063534Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Q47191000Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse.
Q34510789Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn , and LC-HR-MSn.
Q64106117In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)--(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography⁻Mass Spectrometry
Q35779974In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Q93273519Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines
Q39666362Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
Q48362650Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS.
Q92041409Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers
Q90344547NBOMes-Highly Potent and Toxic Alternatives of LSD
Q91833440Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings

Search more.